Market Research Report
U.S. Market for Minimally Invasive Bariatric Surgical Devices
|Published by||Medtech Insight||Product code||177646|
|Published||Content info||232 Pages
Delivery time: 1-2 business days
|U.S. Market for Minimally Invasive Bariatric Surgical Devices|
|Published: March 24, 2011||Content info: 232 Pages||
This publication has been discontinued on July 3, 2017.
An estimated 200 million adults in the U.S. (a staggering 68% of the adult population) are categorized as overweight or obese. Obesity is the, second-leading cause of preventable death in the U.S. resulting in nearly 112,000 deaths annually. The condition is a leading cause of type 2 diabetes, disability, and heart disease, and is a significant contributor to rising healthcare costs. Despite the dire need for weight loss in the majority of the adult population, research has found that diet and exercise alone is unsuccessful in 80-85% of patients at one year, and only approximately 1% of the eligible obese population currently undergoes bariatric surgery due to high cost and high risk of complications. This presents a significant unmet need for less invasive weight loss treatments. Although more clinical research is required, minimally invasive bariatric surgical devices and systems may provide a less costly, safe and effective - and potentially lifesaving - weight loss alternative.
While current economic conditions continue to restrain market growth, the U.S. market for minimally invasive bariatric surgical devices is expected to exhibit relatively strong growth over the next 5 years. Valued at more than $345 million in 2010, the U.S. minimally invasive bariatric surgical products market is expected to increase at a healthy compound annual rate of 6.6%, with sales reaching more than $500 million in 2016.
The market is expected to benefit from increased utilization of laparoscopic adjustable gastric banding systems and emerging incisionless technologies, including intragastric balloons and other transorally inserted weight loss devices, as well as implantable gastric stimulators or vagal blocking systems. The market is also expected to benefit from growing usage of single-incision surgery; minimally invasive robotic surgery is also expected to continue to significantly improve bariatric surgical outcomes.
This dynamic report from Medtech Insight includes analyses of products, markets, competitors, and emerging technology and opportunities. Covered topics in this report include laparoscopic adjustable gastric banding (LAGB) systems; intragastric balloon systems; emerging transorally inserted weight loss devices; single-incision technologies; minimally invasive robotic systems; and implantable gastric stimulation/vagal blocking systems.